Back to mobile site

Ocular Therapeutix (OCUL) Announces Strategic Update and Operational Restructuring

November 8, 2019 4:02 PM EST Send to a Friend
Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login